Physician profile
Whitney L Thomas
NPI 1821447806
$4,957.40
in general payments reported to CMS, 2019-2025
27 companies · $331 in 2025
The $331 reported for 2025 was more than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $366 · 2022: $513 · 2024: $3,748 · 2025: $331.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $2,250 · Food and Beverage: $1,076 · Travel and Lodging: $752.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $2,250.00 |
| Food and Beverage | $1,076.33 |
| Travel and Lodging | $752.26 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $3,036.92 | 2024 | |
| Coloplast Corp | $331.99 | 2024 | |
| Abbvie INC. | $221.49 | 2021-2022 | |
| Evofem Biosciences, INC. | $203.93 | 2021-2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $136.17 | 2022-2025 | |
| Shield Therapeutics INC | $87.08 | 2024 | |
| Hologic Sales and Service, LLC | $83.08 | 2021-2024 | Aptima |
| Astellas Pharma US INC | $82.41 | 2022-2024 | Veozah |
| Mayne Pharma Commercial LLC | $77.28 | 2021-2025 | |
| Daiichi Sankyo INC. | $76.06 | 2022 | |
| Merck Sharp & Dohme LLC | $75.74 | 2021-2025 | Gardasil 9, Gardasil |
| Smith+Nephew, INC. | $71.45 | 2022-2025 | Grafix Pl, Stravix |
| Myovant Sciences INC. | $54.75 | 2021-2022 | |
| Teleflex LLC | $45.97 | 2025 | Quikclot |
| Davol INC. | $44.02 | 2024 | Arista Ah Flexitip |
Show all 27 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Channel Medsystems, INC. | $40.59 | 2024 | |
| Sumitomo Pharma America, INC. | $40.33 | 2025 | Gemtesa |
| Exeltis, USA INC. | $39.45 | 2022 | |
| Organon LLC | $39.44 | 2021-2022 | |
| Therapeuticsmd, INC. | $31.84 | 2022 | |
| Sage Therapeutics, LLC | $31.79 | 2024-2025 | Zurzuvae |
| Roche Diagnostics Corporation | $21.17 | 2021 | |
| Exact Sciences Corporation | $19.91 | 2025 | Cologuard Collection Kit |
| Avion Pharmaceuticals | $19.29 | 2021 | |
| Becton, Dickinson and Company | $17.00 | 2025 | Bd Onclarity |
| Coopersurgical, INC. | $14.53 | 2024 | Paragard T 380a |
| Pfizer INC. | $13.72 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Whitney Thomas listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.